STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Exicure, Inc. to Present at the virtual Fall Investor Summit on November 16th-18th

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Exicure, Inc. (NYSE American:XCUR) will present at the virtual Fall Investor Summit from November 16-18, 2020. This event includes 75 companies and over 300 institutional and retail investors. Exicure focuses on developing nucleic acid-based therapeutics for rare genetic diseases and cancer. Their proprietary spherical nucleic acid (SNA) technology aims to improve drug efficacy across various cells and tissues. The conference connects smallcap and microcap companies with qualified investors, offering a platform for valuable networking.

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

NEW YORK, NY / ACCESSWIRE / November 12, 2020 / Exicure, Inc. (NYSE American:XCUR), is developing nucleic acid-based therapeutics to treat rare, severe genetic diseases and cancer. XCUR will be presenting at this year's virtual Fall Investor Summit on November 16th-18th.

The Fall Investor Summit will take place virtually, featuring 75 companies and over 300 institutional and retail investors.

About Exicure, Inc.

Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary spherical nucleic acid (SNA™) architecture is designed to unlock the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address inflammatory diseases, genetic disorders and oncology. Exicure is based in Chicago, IL.

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors.

To register as a presenting company: please contact Brittney Blocker (brittney@investorsummitgroup.com)

To request complimentary investor registration: please visit our website at www.investorsummitgroup.com

News Compliments of ACCESSWIRE

FOR MORE INFORMATION

Please visit: www.investorsummitgroup.com

Or, contact Brittney Blocker at brittney@investorsummitgroup.com

SOURCE: Exicure, Inc.



View source version on accesswire.com:
https://www.accesswire.com/615958/Exicure-Inc-to-Present-at-the-virtual-Fall-Investor-Summit-on-November-16th-18th

FAQ

What is Exicure, Inc. (XCUR) presenting at the Fall Investor Summit?

Exicure, Inc. will present its nucleic acid-based therapeutics at the virtual Fall Investor Summit from November 16-18, 2020.

When is the Fall Investor Summit taking place?

The Fall Investor Summit is scheduled for November 16-18, 2020.

How many companies are participating in the Fall Investor Summit 2020?

There will be 75 companies participating in the Fall Investor Summit 2020.

What type of therapies is Exicure, Inc. developing?

Exicure, Inc. is developing nucleic acid-based therapeutics for rare genetic diseases and cancer.

Where is Exicure, Inc. based?

Exicure, Inc. is based in Chicago, IL.
Exicure Inc

NASDAQ:XCUR

XCUR Rankings

XCUR Latest News

XCUR Latest SEC Filings

XCUR Stock Data

23.65M
2.38M
63.15%
12.88%
0.48%
Biotechnology
Pharmaceutical Preparations
Link
United States
CHICAGO